MX9704738A - Analogos de peptido p277 y composiciones farmaceuticas que los contienen, metodo de diagnostico de diabetes mellitus dependiente de la insulina y uso de los mismos. - Google Patents
Analogos de peptido p277 y composiciones farmaceuticas que los contienen, metodo de diagnostico de diabetes mellitus dependiente de la insulina y uso de los mismos.Info
- Publication number
- MX9704738A MX9704738A MX9704738A MX9704738A MX9704738A MX 9704738 A MX9704738 A MX 9704738A MX 9704738 A MX9704738 A MX 9704738A MX 9704738 A MX9704738 A MX 9704738A MX 9704738 A MX9704738 A MX 9704738A
- Authority
- MX
- Mexico
- Prior art keywords
- peptide
- analogs
- diabetes
- diagnosis
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Veterinary Medicine (AREA)
- Rehabilitation Therapy (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Un péptido que tiene la estructura de la secuencia p277 de hsp60, en donde uno o ambos residuos de cisteina están reemplazados por residuos de valina y/o en donde el residuo Thr19 está reemplazado por Lys, tiene sustancialmente la misma actividad biologica que p277, peor con estabilidad sustancialmente mejorada. Los análogos de p277 novedosos pueden ser usados para todos los propositos para los que puede usarse p277.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL11209494A IL112094A0 (en) | 1994-12-21 | 1994-12-21 | Novel peptides and pharmaceutical compositions comprising them |
IL11446095A IL114460A0 (en) | 1995-07-05 | 1995-07-05 | Peptide p277 analogs and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes |
PCT/US1995/016596 WO1996019236A1 (en) | 1994-12-21 | 1995-12-20 | PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR TREATMENT OR DIAGNOSIS OF DIABETES |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9704738A true MX9704738A (es) | 1997-10-31 |
Family
ID=26322965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9704738A MX9704738A (es) | 1994-12-21 | 1995-12-20 | Analogos de peptido p277 y composiciones farmaceuticas que los contienen, metodo de diagnostico de diabetes mellitus dependiente de la insulina y uso de los mismos. |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP0820303B1 (es) |
JP (2) | JP3420245B2 (es) |
KR (1) | KR100400480B1 (es) |
CN (1) | CN1233417C (es) |
AR (1) | AR002949A1 (es) |
AT (1) | ATE242005T1 (es) |
AU (1) | AU707835B2 (es) |
BR (1) | BR9510102A (es) |
CA (1) | CA2208274C (es) |
CZ (1) | CZ293784B6 (es) |
DE (2) | DE820303T1 (es) |
DK (1) | DK0820303T3 (es) |
ES (1) | ES2201137T3 (es) |
FI (1) | FI118373B (es) |
HR (1) | HRP950612B1 (es) |
HU (1) | HU224160B1 (es) |
IL (1) | IL116499A0 (es) |
IS (1) | IS1966B (es) |
MX (1) | MX9704738A (es) |
NO (1) | NO317350B1 (es) |
NZ (1) | NZ301440A (es) |
PL (1) | PL184145B1 (es) |
PT (1) | PT820303E (es) |
RO (1) | RO116777B1 (es) |
RS (1) | RS49517B (es) |
SI (1) | SI0820303T1 (es) |
TR (1) | TR199501630A2 (es) |
TW (1) | TW496872B (es) |
UA (1) | UA42040C2 (es) |
UY (1) | UY24130A1 (es) |
WO (1) | WO1996019236A1 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6488933B2 (en) | 1995-07-05 | 2002-12-03 | Yeda Research And Development Co. Ltd. | Preparations for the treatment of T cell mediated diseases |
DE69724619T2 (de) * | 1996-05-14 | 2004-07-01 | Winnacker, Ernst-Ludwig, Prof. | Chaperone, die prionproteine binden und zwischen den isoformen prpc und prpsc unterscheiden können |
EP1335741A4 (en) * | 2000-08-25 | 2005-10-26 | Yeda Res & Dev | METHOD FOR THE PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDES (04.03.02) |
IL140233A0 (en) * | 2000-12-11 | 2002-02-10 | Peptor Ltd | Backbone cyclized analogs of heat shock proteins |
WO2003063759A2 (en) | 2002-01-31 | 2003-08-07 | Peptor Ltd. | Hsp peptides and analogs for modulation of immune responses via antigen presenting cells |
CA2595520A1 (en) | 2004-01-28 | 2005-08-11 | Develogen Israel Ltd. | Hsp therapy in conjunction with a low antigenicity diet |
DE102004043750A1 (de) * | 2004-09-10 | 2006-03-30 | Sanofi-Aventis Deutschland Gmbh | Formulierungen des Peptids p277 oder dessen Varianten mit optimierter Stabilität |
CN100352502C (zh) * | 2004-12-29 | 2007-12-05 | 中国药科大学 | 能通过免疫防治ⅰ型糖尿病的重组蛋白和重组基因 |
US8691772B2 (en) | 2005-01-04 | 2014-04-08 | Yeda Research And Development Co. Ltd. | HSP60, HSP60 peptides and T cell vaccines for immunomodulation |
EP1858545A2 (en) * | 2005-03-04 | 2007-11-28 | Curedm Inc. | Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions |
EP2295066B1 (en) | 2005-05-25 | 2016-04-27 | CureDM Group Holdings, LLC | Peptides, derivatives and analogs thereof, and methods of using same |
JP4283812B2 (ja) * | 2006-01-06 | 2009-06-24 | 財団法人工業技術研究院 | 重症筋無力症の診断方法およびそのキット |
WO2008064306A2 (en) | 2006-11-22 | 2008-05-29 | Curedm, Inc. | Methods and compositions relating to islet cell neogenesis |
MX337147B (es) | 2007-08-30 | 2016-02-15 | Curedm Group Holdings Llc | Composiciones y metodos para utilizar peptidos proislet y sus analogos. |
CU23701A1 (es) * | 2008-12-29 | 2011-09-21 | Ct Ingenieria Genetica Biotech | Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i |
CN104203263A (zh) | 2012-03-01 | 2014-12-10 | 耶达研究与发展有限公司 | 利用HSP60衍生肽再生胰岛β细胞 |
WO2013128450A1 (en) | 2012-03-01 | 2013-09-06 | Yeda Research And Development Co. Ltd. | Hsp60 derived peptides and peptide analogs for suppression and treatment of non-autoimmune diabetes |
CN104418948B (zh) * | 2013-09-10 | 2019-08-16 | 深圳翰宇药业股份有限公司 | 一种制备多肽药物的方法 |
CN104650209B (zh) * | 2013-11-19 | 2018-04-06 | 深圳翰宇药业股份有限公司 | 多肽药物DiaPep277 的合成方法 |
CN104650244B (zh) * | 2015-01-21 | 2017-12-08 | 中国药科大学 | 一种具有降血糖兼调脂作用的表位组合肽及其用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5114844A (en) * | 1989-03-14 | 1992-05-19 | Yeda Research And Development Co., Ltd. | Diagnosis and treatment of insulin dependent diabetes mellitus |
-
1995
- 1995-12-20 NZ NZ301440A patent/NZ301440A/xx not_active IP Right Cessation
- 1995-12-20 AU AU46866/96A patent/AU707835B2/en not_active Expired
- 1995-12-20 WO PCT/US1995/016596 patent/WO1996019236A1/en active Search and Examination
- 1995-12-20 JP JP51996596A patent/JP3420245B2/ja not_active Expired - Fee Related
- 1995-12-20 UA UA97063404A patent/UA42040C2/uk unknown
- 1995-12-20 BR BR9510102A patent/BR9510102A/pt active IP Right Grant
- 1995-12-20 RO RO97-01173A patent/RO116777B1/ro unknown
- 1995-12-20 HU HU9901771A patent/HU224160B1/hu active IP Right Grant
- 1995-12-20 EP EP95944502A patent/EP0820303B1/en not_active Expired - Lifetime
- 1995-12-20 CZ CZ19971908A patent/CZ293784B6/cs not_active IP Right Cessation
- 1995-12-20 DE DE0820303T patent/DE820303T1/de active Pending
- 1995-12-20 PT PT95944502T patent/PT820303E/pt unknown
- 1995-12-20 SI SI9530664T patent/SI0820303T1/xx unknown
- 1995-12-20 AT AT95944502T patent/ATE242005T1/de active
- 1995-12-20 ES ES95944502T patent/ES2201137T3/es not_active Expired - Lifetime
- 1995-12-20 CA CA002208274A patent/CA2208274C/en not_active Expired - Lifetime
- 1995-12-20 DK DK95944502T patent/DK0820303T3/da active
- 1995-12-20 MX MX9704738A patent/MX9704738A/es unknown
- 1995-12-20 PL PL95321091A patent/PL184145B1/pl unknown
- 1995-12-20 KR KR1019970704281A patent/KR100400480B1/ko not_active IP Right Cessation
- 1995-12-20 CN CNB95197680XA patent/CN1233417C/zh not_active Expired - Lifetime
- 1995-12-20 DE DE69531004T patent/DE69531004T2/de not_active Expired - Lifetime
- 1995-12-21 RS YU78795A patent/RS49517B/sr unknown
- 1995-12-21 UY UY24130A patent/UY24130A1/es unknown
- 1995-12-21 HR HR950612A patent/HRP950612B1/xx not_active IP Right Cessation
- 1995-12-21 AR AR10071295A patent/AR002949A1/es unknown
- 1995-12-21 IL IL11649995A patent/IL116499A0/xx not_active IP Right Cessation
- 1995-12-21 TR TR95/01630A patent/TR199501630A2/xx unknown
-
1996
- 1996-01-05 TW TW085100088A patent/TW496872B/zh not_active IP Right Cessation
-
1997
- 1997-06-19 IS IS4510A patent/IS1966B/is unknown
- 1997-06-19 FI FI972669A patent/FI118373B/fi not_active IP Right Cessation
- 1997-06-19 NO NO19972849A patent/NO317350B1/no not_active IP Right Cessation
-
2003
- 2003-01-30 JP JP2003022033A patent/JP3554319B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9704738A (es) | Analogos de peptido p277 y composiciones farmaceuticas que los contienen, metodo de diagnostico de diabetes mellitus dependiente de la insulina y uso de los mismos. | |
RU2214418C2 (ru) | Аналоги glp-1 | |
ES2106721T3 (es) | Uso de amilina o cgrp para el tratamiento de la diabetes mellitus. | |
MD960317A (ro) | Noile peptide-agoniste ale amilinei şi utilizarea lor | |
NO905472D0 (no) | Insulinanaloger fra menneske og blandinger som inneholderdem. | |
HUP0100928A2 (hu) | Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
PT699686E (pt) | Fragmentos de peptido insulinotropico do tipo glucagona biologicamente activos | |
NZ517012A (en) | Peptides that lower blood glucose levels | |
RU93053497A (ru) | Новые пептиды-агонисты и их использование | |
AU6020099A (en) | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein | |
MX9703642A (es) | Metodos para el tratamiento de esclerosis multiple utilizando analogos de peptido en la posicion 91 de la proteina basica de mielina humana. | |
MX9203879A (es) | Muteina de il-6 con cisteina parcialmente suprimida. | |
KR980002066A (ko) | 변이형 인간 성장호르몬 및 그의 용도 | |
FI971427A (fi) | Peptidit ja niitä sisältävät farmaseuttiset koostumukset | |
DE69326145T2 (de) | Synthetische peptide für die behandlung von myasthenia gravis | |
WO2004111086A3 (fr) | ANALOGUES PEPTIDIQUES COMPRENANT AU MOINS UN RESIDU AZA-ß3 AMINOACYLE, ET LEURS UTILISATIONS, NOTAMMENT EN THERAPIE | |
AU1464488A (en) | Human rhinovirus peptides | |
DK0423326T3 (da) | Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta | |
MX9800239A (es) | Metodos para el tratamiento y prevencion de diabetes. |